In contrast to their Xbox-playing brethren, women constitute as much as 70% of the smartphone and tablet gaming audience. But the volatile mobile market, marked by few paying customers and even fewer smash hits, has yet to properly tap into this valuable demographic, say some analysts. Women could bring some stability and an influx of revenue to this lopsided boom-bust sector, just as it is set to overtake the console market as the
In a move analysts call good for the next earnings report and beyond, Tesla Motors (TSLA) outran its own guidance Thursday, announcing second-quarter deliveries of 11,507 Model S sedans — vs. the 10,000 to 11,000 anticipated. Tesla stock set a new 10-month high in the stock market today, reaching 282.45 following the morning announcement, before closing up 4% at 279.95. Tesla stock has risen 25% this year. “First of all, it’s good for the
The FDA on Thursday afternoon approved Vertex Pharmaceuticals’ (VRTX) potential blockbuster cystic-fibrosis drug Orkambi, which the company priced at $259,000 per year, on the high side of investors’ expectations. The agency gave the nod to Orkambi, a combination of ivacaftor (which Vertex markets separately as Kalydeco) and lumacaftor, a booster that makes the drug effective in treating a much larger population than ivacaftor alone. The FDA